Wall Street gains as the new trading week begins. The US100 is currently up 1.5%, while the US500 is up 1.3%. As the upcoming April 2 deadline for finalizing all changes to mutual tariffs becomes priced in by markets, Trump’s new comments about possible flexibility on trade are increasing risk appetite. What’s more, the expiration of the previous futures contracts, which end the first quarterly market trading of 2025, is reallocating some capital that was recently under pressure from a 10%+ decline in major US indices.
The US100 is already up 1.5% and is back above the 200-day EMA (golden line on the chart). Source: xStation
Among the individual stocks, Tesla stands out today, currently up 10% and leading the gains among the Magnificent Seven tech stocks. At the same time, Meta shares rose 3.55%, Nvidia and Amazon each gained 3.3%, Alphabet rose 2.0%, Microsoft gained 0.21% and Apple gained 0.5%.
Tesla is moving forward with the process of obtaining Chinese regulatory approval for its more advanced driver assistance features in hardware 3.0 and 4.0. The company plans to introduce its intelligent driving assistance feature in China once the relevant software is approved.
Big Techs lead today’s gains. Source: xStation
Daily Summary: U.S. stock indices are climbing following the PPI data
AI needs power and thatโs where the profits are. Oracle and Bloom set the path.
US OPEN: Wall Street Rallies on Soft PPI Data
Novo Nordisk announces a strategic partnership with OpenAI๐งฌ๐ค
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
